Julio Rosenstock
Dallas Diabetes and Endocrine Center at Medical City
Dallas
Texas
USA
Name/email consistency: high
- Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes. Rosenstock, J., Aggarwal, N., Polidori, D., Zhao, Y., Arbit, D., Usiskin, K., Capuano, G., Canovatchel, W. Diabetes. Care (2012)
- Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes. Rosenstock, J., Hernandez-Triana, E., Handelsman, Y., Misir, S., Jones, M.R. Postgrad. Med (2012)
- Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes. Rosenstock, J., Hernandez-Triana, E., Handelsman, Y., Misir, S., Jones, M.R., Nagendran, S. Postgrad. Med (2012)
- Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy. Rosenstock, J., Vico, M., Wei, L., Salsali, A., List, J.F. Diabetes. Care (2012)
- Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes. Rosenstock, J., Lewin, A.J., Norwood, P., Somayaji, V., Nguyen, T.T., Teeter, J.G., Johnson, S.L., Dai, H., Terra, S.G. Diabet. Med. (2011)
- Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. Rosenstock, J., Lorber, D.L., Gnudi, L., Howard, C.P., Bilheimer, D.W., Chang, P.C., Petrucci, R.E., Boss, A.H., Richardson, P.C. Lancet (2010)
- Initial combination therapy with alogliptin and pioglitazone in drug-naïve patients with type 2 diabetes. Rosenstock, J., Inzucchi, S.E., Seufert, J., Fleck, P.R., Wilson, C.A., Mekki, Q. Diabetes. Care (2010)
- Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes. Rosenstock, J., Fonseca, V.A., Garvey, W.T., Goldberg, R.B., Handelsman, Y., Abby, S.L., Lai, Y.L., Jin, X., Misir, S., Nagendran, S., Jones, M.R. Endocr. Pract (2010)
- Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes. Rosenstock, J., Klaff, L.J., Schwartz, S., Northrup, J., Holcombe, J.H., Wilhelm, K., Trautmann, M. Diabetes. Care (2010)
- Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Rosenstock, J., Aguilar-Salinas, C., Klein, E., Nepal, S., List, J., Chen, R. Curr. Med. Res. Opin (2009)
- Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial. Rosenstock, J., Cefalu, W.T., Hollander, P.A., Klioze, S.S., Reis, J., Duggan, W.T. Diabetes Technol. Ther. (2009)
- Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Rosenstock, J., Fonseca, V., McGill, J.B., Riddle, M., Hallé, J.P., Hramiak, I., Johnston, P., Davis, M. Diabetologia (2009)
- Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus. Rosenstock, J., Niggli, M., Maldonado-Lutomirsky, M. Diabetes. Obes. Metab (2009)
- Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia. Rosenstock, J., Rendell, M.S., Gross, J.L., Fleck, P.R., Wilson, C.A., Mekki, Q. Diabetes. Obes. Metab (2009)
- Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing. Rosenstock, J., Reusch, J., Bush, M., Yang, F., Stewart, M. Diabetes. Care (2009)
- A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Rosenstock, J., Davies, M., Home, P.D., Larsen, J., Koenen, C., Schernthaner, G. Diabetologia (2008)
- Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes. Rosenstock, J., Chou, H.S., Matthaei, S., Seidel, D.K., Hamann, A. Diabetes. Obes. Metab (2008)
- Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes. Rosenstock, J., Sankoh, S., List, J.F. Diabetes. Obes. Metab (2008)
- Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes. Rosenstock, J., Cefalu, W.T., Hollander, P.A., Belanger, A., Eliaschewitz, F.G., Gross, J.L., Klioze, S.S., St Aubin, L.B., Foyt, H., Ogawa, M., Duggan, W.T. Diabetes. Care (2008)
- Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes. Rosenstock, J., Fitchet, M. Int. J. Clin. Pract. Suppl (2008)
- SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes. Rosenstock, J., Hollander, P., Chevalier, S., Iranmanesh, A. Diabetes. Care (2008)
- Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents. Rosenstock, J., Bergenstal, R., Defronzo, R.A., Hirsch, I.B., Klonoff, D., Boss, A.H., Kramer, D., Petrucci, R., Yu, W., Levy, B. Diabetes. Care (2008)
- Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy. Rosenstock, J., Ahmann, A.J., Colon, G., Scism-Bacon, J., Jiang, H., Martin, S. Diabetes. Care (2008)
- A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients. Rosenstock, J., Hollander, P., Gadde, K.M., Sun, X., Strauss, R., Leung, A. Diabetes. Care (2007)
- Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus. Rosenstock, J., Zinman, B. Curr. Opin. Endocrinol. Diabetes. Obes (2007)
- AIR Inhaled Insulin System: a novel insulin-delivery system for patients with diabetes. Rosenstock, J., Muchmore, D., Swanson, D., Schmitke, J. Expert. Rev. Med. Devices (2007)
- Reflecting on type 2 diabetes prevention: more questions than answers! Rosenstock, J. Diabetes. Obes. Metab (2007)
- Comparison of standard (self-directed) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measures. Rosenstock, J., Nakano, M., Silverman, B.L., Sun, B., de la Peña, A., Suri, A., Muchmore, D.B. Diabetes Technol. Ther. (2007)
- Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Rosenstock, J., Baron, M.A., Dejager, S., Mills, D., Schweizer, A. Diabetes. Care (2007)
- Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study. Rosenstock, J., Goldstein, B.J., Vinik, A.I., O'neill, M.C., Porter, L.E., Heise, M.A., Kravitz, B., Dirani, R.G., Freed, M.I. Diabetes. Obes. Metab (2006)
- Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Rosenstock, J., Sugimoto, D., Strange, P., Stewart, J.A., Soltes-Rak, E., Dailey, G. Diabetes. Care (2006)
- Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control. Rosenstock, J., Rood, J., Cobitz, A., Huang, C., Garber, A. Diabetes. Obes. Metab (2006)
- Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes. Rosenstock, J., Rood, J., Cobitz, A., Biswas, N., Chou, H., Garber, A. Diabetes. Obes. Metab (2006)
- Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Rosenstock, J., Dailey, G., Massi-Benedetti, M., Fritsche, A., Lin, Z., Salzman, A. Diabetes. Care (2005)
- Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Rosenstock, J., Zinman, B., Murphy, L.J., Clement, S.C., Moore, P., Bowering, C.K., Hendler, R., Lan, S.P., Cefalu, W.T. Ann. Intern. Med. (2005)
- Repaglinide versus nateglinide monotherapy: a randomized, multicenter study. Rosenstock, J., Hassman, D.R., Madder, R.D., Brazinsky, S.A., Farrell, J., Khutoryansky, N., Hale, P.M. Diabetes. Care (2004)
- Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Rosenstock, J., Tuchman, M., LaMoreaux, L., Sharma, U. Pain (2004)
- Redefining insulin therapy in type 2 diabetes mellitus. Rosenstock, J. Postgrad. Med (2004)
- Management of type 2 diabetes mellitus in the elderly: special considerations. Rosenstock, J. Drugs. Aging (2001)
- Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Rosenstock, J., Schwartz, S.L., Clark, C.M., Park, G.D., Donley, D.W., Edwards, M.B. Diabetes. Care (2001)
- Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group. Rosenstock, J., Park, G., Zimmerman, J. Diabetes. Care (2000)
